Table 2.
Provider Responses (N = 615) to Questions Concerning Perinatal Cannabis Use
| Provider responses, N (%) | Provider responses regarding safety of cannabis use/exposure, n (%)a |
Provider responses encouraging or discouraging use/exposure, n (%) |
||||||
|---|---|---|---|---|---|---|---|---|
| Harmful | Safe | Mixed/Unsure | Not addressed | Discourage | Encourage | Not addressed | ||
| Total | 615 (100) | 342 (55.6) | 54 (8.8) | 54 (8.8) | 165 (26.8) | 305 (49.6) | 3 (0.5) | 307 (49.9) |
| Question category | ||||||||
| Exposure before pregnancy | ||||||||
| Ability to conceive | 130 (21.8) | 86 (66.2) | 18 (13.9) | 11 (8.5) | 15 (11.5) | 45 (34.6) | 0 (0) | 85 (65.4) |
| Health effects | 6 (1.0) | 3 (50.0) | 1 (16.7) | 2 (33.3) | 0 (0) | 3 (50.0) | 0 (0) | 3 (50.0) |
| Exposure during pregnancy | ||||||||
| Maternal use | 143 (24.0) | 110 (76.9) | 7 (4.9) | 14 (9.8) | 12 (8.4) | 82 (57.3) | 2 (1.4) | 59 (41.3) |
| Second/Third-hand smoke | 31 (5.2) | 8 (25.8) | 15 (48.4) | 5 (16.1) | 3 (9.7) | 13 (41.9) | 0 (0) | 18 (58.1) |
| Quitting use | 4 (0.7) | 1 (25.0) | 0 (0) | 0 (0) | 3 (75.0) | 4 (100) | 0 (0) | 0 (0) |
| Benefits of use | 3 (0.5) | 1 (33.3) | 0 (0) | 0 (0) | 2 (66.7) | 1 (33.3) | 0 (0) | 2 (66.7) |
| Exposure postpartum | ||||||||
| Use and breastfeeding | 99 (16.6) | 63 (63.6) | 3 (3.0) | 10 (10.1) | 23 (23.2) | 65 (65.7) | 0 (0) | 34 (34.3) |
| Second/Third-hand smoke | 19 (3.2) | 11 (57.9) | 3 (15.8) | 3 (15.8) | 2 (10.5) | 7 (36.8) | 0 (0) | 12 (63.2) |
| Return to use | 8 (1.3) | 3 (37.5) | 1 (12.5) | 2 (25.0) | 2 (25.0) | 4 (50.0) | 1 (12.5) | 3 (37.5) |
| Cannabis detection | ||||||||
| Detection | 135 (22.7) | 43 (31.9) | 5 (3.7) | 7 (5.2) | 80 (59.3) | 64 (47.4) | 0 (0) | 71 (52.6) |
| Legal implications | 37 (6.2) | 13 (35.1) | 1 (2.7) | 0 (0) | 23 (62.2) | 17 (46.0) | 0 (0) | 20 (54.1) |
a
Safety of cannabis use (harmful, not harmful, mixed/unsure, not addressed) for ability to conceive relates specifically to whether there are impacts on fertility (i.e., harmful = impacts on fertility). In all other categories, safety of cannabis use relates to whether use is harmful during pregnancy and postpartum. Provider responses could address questions that fell into multiple categories. There were 596 unique provider responses and 615 response codes (17 additional codes came from provider responses to the 10 double-coded questions and 2 additional codes came from provider responses to the 1 triple-coded question).